FIGURE 2.
Kaplan–Meier curves for progression‐free survival (PFS) and overall survival (OS) for KRD (A; PFS, B; OS) and KD (C; PFS, D; OS) therapy, according to refractoriness to BTZ and/or LEN
Kaplan–Meier curves for progression‐free survival (PFS) and overall survival (OS) for KRD (A; PFS, B; OS) and KD (C; PFS, D; OS) therapy, according to refractoriness to BTZ and/or LEN